2024-04-012025-03-312025-03-31false11813301KARIM DENTAL LTD2025-09-09falseiso4217:GBPxbrli:pure118133012024-03-31118133012025-03-31118133012024-04-012025-03-31118133012023-02-28118133012024-03-31118133012023-03-012024-03-3111813301bus:SmallEntities2024-04-012025-03-3111813301bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3111813301bus:FullAccounts2024-04-012025-03-3111813301bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111813301core:WithinOneYear2025-03-3111813301core:AfterOneYear2025-03-3111813301core:WithinOneYear2024-03-3111813301core:AfterOneYear2024-03-3111813301core:ShareCapital2025-03-3111813301core:SharePremium2025-03-3111813301core:RevaluationReserve2025-03-3111813301core:OtherReservesSubtotal2025-03-3111813301core:RetainedEarningsAccumulatedLosses2025-03-3111813301core:ShareCapital2024-03-3111813301core:SharePremium2024-03-3111813301core:RevaluationReserve2024-03-3111813301core:OtherReservesSubtotal2024-03-3111813301core:RetainedEarningsAccumulatedLosses2024-03-3111813301core:LandBuildings2025-03-3111813301core:PlantMachinery2025-03-3111813301core:Vehicles2025-03-3111813301core:FurnitureFittings2025-03-3111813301core:OfficeEquipment2025-03-3111813301core:NetGoodwill2025-03-3111813301core:IntangibleAssetsOtherThanGoodwill2025-03-3111813301core:ListedExchangeTraded2025-03-3111813301core:UnlistedNon-exchangeTraded2025-03-3111813301core:LandBuildings2024-03-3111813301core:PlantMachinery2024-03-3111813301core:Vehicles2024-03-3111813301core:FurnitureFittings2024-03-3111813301core:OfficeEquipment2024-03-3111813301core:NetGoodwill2024-03-3111813301core:IntangibleAssetsOtherThanGoodwill2024-03-3111813301core:ListedExchangeTraded2024-03-3111813301core:UnlistedNon-exchangeTraded2024-03-3111813301core:LandBuildings2024-04-012025-03-3111813301core:PlantMachinery2024-04-012025-03-3111813301core:Vehicles2024-04-012025-03-3111813301core:FurnitureFittings2024-04-012025-03-3111813301core:OfficeEquipment2024-04-012025-03-3111813301core:NetGoodwill2024-04-012025-03-3111813301core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111813301core:ListedExchangeTraded2024-04-012025-03-3111813301core:UnlistedNon-exchangeTraded2024-04-012025-03-3111813301core:MoreThanFiveYears2024-04-012025-03-3111813301core:Non-currentFinancialInstruments2025-03-3111813301core:Non-currentFinancialInstruments2024-03-3111813301dpl:CostSales2024-04-012025-03-3111813301dpl:DistributionCosts2024-04-012025-03-3111813301core:LandBuildings2024-04-012025-03-3111813301core:PlantMachinery2024-04-012025-03-3111813301core:Vehicles2024-04-012025-03-3111813301core:FurnitureFittings2024-04-012025-03-3111813301core:OfficeEquipment2024-04-012025-03-3111813301dpl:AdministrativeExpenses2024-04-012025-03-3111813301core:NetGoodwill2024-04-012025-03-3111813301core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111813301dpl:GroupUndertakings2024-04-012025-03-3111813301dpl:ParticipatingInterests2024-04-012025-03-3111813301dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111813301core:ListedExchangeTraded2024-04-012025-03-3111813301dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111813301core:UnlistedNon-exchangeTraded2024-04-012025-03-3111813301dpl:CostSales2023-03-012024-03-3111813301dpl:DistributionCosts2023-03-012024-03-3111813301core:LandBuildings2023-03-012024-03-3111813301core:PlantMachinery2023-03-012024-03-3111813301core:Vehicles2023-03-012024-03-3111813301core:FurnitureFittings2023-03-012024-03-3111813301core:OfficeEquipment2023-03-012024-03-3111813301dpl:AdministrativeExpenses2023-03-012024-03-3111813301core:NetGoodwill2023-03-012024-03-3111813301core:IntangibleAssetsOtherThanGoodwill2023-03-012024-03-3111813301dpl:GroupUndertakings2023-03-012024-03-3111813301dpl:ParticipatingInterests2023-03-012024-03-3111813301dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-03-3111813301core:ListedExchangeTraded2023-03-012024-03-3111813301dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-03-3111813301core:UnlistedNon-exchangeTraded2023-03-012024-03-3111813301core:NetGoodwill2025-03-3111813301core:IntangibleAssetsOtherThanGoodwill2025-03-3111813301core:LandBuildings2025-03-3111813301core:PlantMachinery2025-03-3111813301core:Vehicles2025-03-3111813301core:FurnitureFittings2025-03-3111813301core:OfficeEquipment2025-03-3111813301core:AfterOneYear2025-03-3111813301core:WithinOneYear2025-03-3111813301core:ListedExchangeTraded2025-03-3111813301core:UnlistedNon-exchangeTraded2025-03-3111813301core:ShareCapital2025-03-3111813301core:SharePremium2025-03-3111813301core:RevaluationReserve2025-03-3111813301core:OtherReservesSubtotal2025-03-3111813301core:RetainedEarningsAccumulatedLosses2025-03-3111813301core:NetGoodwill2024-03-3111813301core:IntangibleAssetsOtherThanGoodwill2024-03-3111813301core:LandBuildings2024-03-3111813301core:PlantMachinery2024-03-3111813301core:Vehicles2024-03-3111813301core:FurnitureFittings2024-03-3111813301core:OfficeEquipment2024-03-3111813301core:AfterOneYear2024-03-3111813301core:WithinOneYear2024-03-3111813301core:ListedExchangeTraded2024-03-3111813301core:UnlistedNon-exchangeTraded2024-03-3111813301core:ShareCapital2024-03-3111813301core:SharePremium2024-03-3111813301core:RevaluationReserve2024-03-3111813301core:OtherReservesSubtotal2024-03-3111813301core:RetainedEarningsAccumulatedLosses2024-03-3111813301core:NetGoodwill2023-02-2811813301core:IntangibleAssetsOtherThanGoodwill2023-02-2811813301core:LandBuildings2023-02-2811813301core:PlantMachinery2023-02-2811813301core:Vehicles2023-02-2811813301core:FurnitureFittings2023-02-2811813301core:OfficeEquipment2023-02-2811813301core:AfterOneYear2023-02-2811813301core:WithinOneYear2023-02-2811813301core:ListedExchangeTraded2023-02-2811813301core:UnlistedNon-exchangeTraded2023-02-2811813301core:ShareCapital2023-02-2811813301core:SharePremium2023-02-2811813301core:RevaluationReserve2023-02-2811813301core:OtherReservesSubtotal2023-02-2811813301core:RetainedEarningsAccumulatedLosses2023-02-2811813301core:AfterOneYear2024-04-012025-03-3111813301core:WithinOneYear2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111813301core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111813301core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111813301core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111813301core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111813301core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111813301bus:Director12024-04-012025-03-3111813301bus:Director22024-04-012025-03-3111813301core:FurnitureFittingsToolsEquipment2024-04-012025-03-3111813301core:FurnitureFittingsToolsEquipment2025-03-3111813301core:FurnitureFittingsToolsEquipment2024-03-31

KARIM DENTAL LTD

Registered Number
11813301
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

KARIM DENTAL LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Dr. Michaella Gabrielle Beatrice Karim
Sejil Ahmad Karim

Registered Address

16 Chatsworth Parade
Petts Wood
Orpington
BR5 1DF

Registered Number

11813301 (England and Wales)
KARIM DENTAL LTD
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets32,970-
Tangible assets5277,336-
280,306-
Current assets
Stocks711,000-
Debtors848,51778,721
Cash at bank and on hand39,486295,966
99,003374,687
Creditors amounts falling due within one year9(10,484)(57,829)
Net current assets (liabilities)88,519316,858
Total assets less current liabilities368,825316,858
Provisions for liabilities10(25,030)-
Net assets343,795316,858
Capital and reserves
Called up share capital11
Profit and loss account343,794316,857
Shareholders' funds343,795316,858
The financial statements were approved and authorised for issue by the Board of Directors on 9 September 2025, and are signed on its behalf by:
Dr. Michaella Gabrielle Beatrice Karim
Director
Sejil Ahmad Karim
Director

Registered Company No. 11813301
KARIM DENTAL LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 11813301 and registered office address is 16 Chatsworth Parade, Petts Wood, Orpington, England, BR5 1DF.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Revenue from rendering of services
Revenue from the rendering of dental services is recognised by reference to the stage of completion at the reporting date. This is typically determined based on the date the service is performed. For longer-term treatment plans, revenue is recognised based on the proportion of services delivered up to the reporting date, where the outcome can be reliably estimated. Where the outcome of a course of treatment cannot be estimated reliably, revenue is recognised only to the extent that the expenses incurred are recoverable. As the company is not registered for VAT, revenue is stated inclusive of any VAT charged to patients.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortization and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortization is included in 'administrative expenses' in the profit and loss account. The Company has recognized an intangible asset related to the development and creation of its website. The website is amortized over its useful life of 5 years, reflecting the expected period during which the asset will provide economic benefits to the Company. The amortization is charged on a straight-line basis, commencing from the date the website is ready for use. The carrying amount of the website is reviewed annually to ensure it is not impaired.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Land and buildings2-
Plant and machinery-4
Fixtures and fittings-4
Office Equipment-4
Stocks and work in progress
At the year end, the stock has been valued at the lower of cost and net realisable value. The stock consists primarily of dental consumables and materials used in the ordinary course of business. A physical stock take was conducted by the owner of the practice, and the valuation provided is considered to be a true and fair representation of the stock held at the balance sheet date.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20252024
Average number of employees during the year72
3.Intangible assets

Other

Total

££
Cost or valuation
Additions3,4003,400
At 31 March 253,4003,400
Amortisation and impairment
Charge for year430430
At 31 March 25430430
Net book value
At 31 March 252,9702,970
At 31 March 24--
4.Impairment of intangible assets
Intangible assets are reviewed annually for indicators of impairment. If any indication of impairment exists, the recoverable amount of the asset is estimated. No indicators of impairment were identified during the reporting period.
5.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
Additions162,134107,16535,86711,915317,081
At 31 March 25162,134107,16535,86711,915317,081
Depreciation and impairment
Charge for year3,23426,7188,0861,70739,745
At 31 March 253,23426,7188,0861,70739,745
Net book value
At 31 March 25158,90080,44727,78110,208277,336
At 31 March 24-----
6.Impairment of tangible fixed assets
Tangible fixed assets are reviewed for indicators of impairment at each reporting date. If such indicators exist, the recoverable amount is estimated and an impairment loss is recognised where the carrying amount exceeds recoverable amount. No such indicators were noted during the year.
7.Stocks

2025

2024

££
Finished goods11,000-
Total11,000-
8.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables12,140-
Amounts owed by associates and joint ventures / participating interests35,32077,955
Other debtors1,057766
Total48,51778,721
As at the balance sheet date of 31 March 2025, other debtors comprise the following: Prepayments : £991.41 (2023 : £766.09) Social security taxes : £34.92 (2023:nil)
9.Creditors: amounts due within one year

2025

2024

££
Amounts owed to related parties532-
Taxation and social security-57,068
Other creditors7,884-
Accrued liabilities and deferred income2,068761
Total10,48457,829
As at the balance sheet date of 31 March 2025, other creditors comprise the following: Deferred income : £4,739.82 (2023 : nil) Accruals : £2,067.30 (2023 : nil) Wages payable: £3,128.85 (2023 : nil) Pension costs : £15.47 ( 2023:nil)
10.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)25,030-
Total25,030-
11.Other commitments
The Company has entered into a non-cancellable operating lease agreement for office premises with a lease term of 10 years. The annual lease payment is £22,500. As at 31 March 2025, 6 months of the current year's lease payments have been made. The total remaining lease commitment for the unexpired lease term is £213,750, representing 9.5 years of future lease payments. Lease payments are recognized as an expense on a straight-line basis over the lease term. The lease does not transfer substantially all the risks and rewards incidental to ownership of the leased asset to the Company.
12.Share capital
The issued share capital of the company comprises one ordinary share of £1, which remains unchanged from the prior year. The share carries equal voting rights, rights to dividends, and rights to a distribution of capital on winding up. This share is wholly owned by the parent company, M&S Karim Limited.
13.Related party transactions
The Company is a wholly-owned subsidiary of M&S Karim Limited and whose registered office is 16 Chatsworth Parade, Petts Wood, Orpington, Kent, United Kingdom, BR5 1DF . During the year, the Company entered into transactions with both its holding company M&S Karim Ltd and its associate M&S Karim proprieties in the ordinary course of business. These transactions were carried out on normal commercial terms. At 31 March 2025: The Company was owed £532 to M&S Karim Limited. The Company was owed £35,320.32 by M&S Karim Properties Limited. All outstanding balances with related parties are unsecured, interest-free, and have no fixed date for repayment. No guarantees have been given or received in respect of these balances.
14.Controlling party
The company is a wholly owned subsidiary of M&S Karim Ltd, which is the immediate and ultimate controlling party.